Related Experiment Videos
Pseudoscleroderma and phenylketonuria
International Journal of Dermatology
|September 1, 1983
Insights
A phenylketonuria (PKU) patient
Area of Science:
- Biochemistry
- Dermatology
- Pediatrics
Background:
- Phenylketonuria (PKU) is an inherited metabolic disorder.
- PKU requires dietary management to restrict phenylalanine intake.
- Cutaneous manifestations in PKU are rare but can occur.
Observation:
- An infant with partial phenylketonuria presented with pseudoscleroderma.
- Neurologic and skin symptoms were observed concurrently.
- The patient was managed with a phenylalanine-restricted diet.
Findings:
- A phenylalanine-restricted diet led to significant improvement in both neurologic and cutaneous symptoms.
- The duration of follow-up was six years.
- Metabolites of phenylalanine, tryptophan, and tyrosine may play a role in the pathogenesis.
Implications:
- Dietary intervention in PKU can positively impact associated dermatologic conditions.
- Transient hypersensitivity of tissues might link metabolic dysfunction to clinical presentation.
- Further research into the biochemical pathways is warranted to understand PKU's multifaceted effects.
Abstract:
An infant girl with partial phenylketonuria developed pseudoscleroderma. After six years of follow up, both the neurologic and cutaneous conditions improved under a phenylalanine restricted diet. The probable roles of phenylalanine, tryptophan, tyrosine, and their metabolites may cause both conditions through possible transient hypersensitivity of cutaneous and muscular tissues.